Search results
Diensten Tech makes powerful debut, lists with 140% premium on NSE SME
CNBC Awaaz· 2 days agoThe profit per lot is Rs 1,68,000.
Wipro gains on double upgrade from CLSA; check revised target, rationale
CNBC Awaaz· 4 days agoShares of Wipro gained as much as 4 percent after global brokerage CLSA double upgraded the stock.
ICICI Lombard hits new record high on CLSA upgrade, forecasts 7% upside potential
CNBC Awaaz· 1 day agoCLSA upgraded ICICI Lombard to 'outperform' from 'hold' and raised target price to Rs 2,000 per...
Ultratech poised to become new 'Thalaiva' in South post India Cements acquisition, say analysts
CNBC Awaaz· 7 days agoAnalysts predict this deal could lead to a larger stake purchase and establish a new 'Thalaiva'...
Buy UltraTech Cement; target of Rs 13,000: Sharekhan
CNBC Awaaz· 4 days agoSharekhan is bullish on UltraTech Cement has recommended buy rating on the stock with a target price of Rs 13,000 in its research report dated June 28,...
From 'latte makeup' to 'girl dinners,' TikTok has launched tons of trends. Will its influence last?...
The Economic Times· 8 hours agoLess than six years later, the social media platform is deeply woven into the fabric of American consumerism, having shortened the shelf life of trends and revamped how people engage with food ...
FIIs net buy equities worth Rs 5,484 crore, DIIs net sell shares worth Rs 924 crore
CNBC Awaaz· 1 day agoDIIs bought Rs 14,121 crore worth of shares and sold shares worth Rs 15,046 crore. Meanwhile, FIIs...
Trade setup for Thursday: Top 15 things to know before the opening bell
CNBC Awaaz· 1 day agoIf the Nifty 50 manages to hold 24,200, then 24,500 can't be ruled out in the coming sessions. Until...
Sensex crosses 80,000 in a first, Nifty hits record high on positive global cues; HDFC Bank in focus
CNBC Awaaz· 2 days agoBenchmark indices, Nifty and Sensex scaled to fresh record highs on July 03 as global cues uplifted...
Buy Star Health; target of Rs 730: Motilal Oswal
CNBC Awaaz· 6 days agoMotilal Oswal is bullish on Star Health recommended buy rating on the stock with a target price of Rs 730 in its research report dated June 28, 2024.